Loading...
NYSE: DGX
Quest Diagnostics Incorporated
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2002
Market Cap
$21.67B
52w High
$213.50
52w Low
$157.20
P/E
21.80
Volume
159.07K
Outstanding Shares
111.24M
Company profile
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally.
CEOJames E. Davis
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees55,000
IPO dateDec 17, 1996
Valuation
Forward P/E—
EV/EBITDA11.74
Enterprise value$25.76B
Stock splits
Jun 21, 20052:1
Jun 1, 20012:1
Profitability & growth
Revenue growth7.06%
Gross margin33.25%▼2.85%vs FY2024
Operating margin14.15%▲6.54%vs FY2024
ROE13.84%▲7.67%vs FY2024
Analyst consensus
RatingHold
Target price$215.10▲10.42%
13
Buy
18
Hold
3
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 28, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.62
$2.57
Q3FY25
ActualEst.
$2.60
$2.50
Q4FY25
ActualEst.
$2.42
$2.36
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.76B
$2.73B
Q3FY25
ActualEst.
$2.82B
$2.74B
Q4FY25
ActualEst.
$2.81B
$2.75B
Q1FY26
Next Est.
—